Delivery Order SPE2DB20D3505-SPE2DB24FT9Y1
- Not listed
- The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The order, valued at $12,128.51, has a completion date of January 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a ceiling value of $2,177.10 and a period of performance through March 21, 2024. This delivery order is issued under Amerisourcebergen's existing indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 31, 2025,...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $11,611.20, has an ultimate completion date of April 11, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. The contract has a ceiling value of $5,805.60 and a period of performance through April 1, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with a performance period through December...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4564119151 - TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceuticals. The contract has a ceiling value of $5,625.36 and a period of performance through April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a potential value of $1,741.68 and a completion date of February 22, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The delivery order, valued at $3,542.40, has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $13,933.44 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of April 1, 2024. AmerisourceBergen Drug Corp previously received an indefinite delivery contract from DLA Troop Support Medical with a potential value of $999,999,999.00 and a performance...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,031.96 to Amerisourcebergen Drug Corp, the prime contractor, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,169,765 units of the pharmaceutical drug TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract, valued at $1,452.75, has an ultimate completion date of April 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB24FT9Y1Delivery Order
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a ceiling value of $1,015.98 and a period of performance through March 29, 2024. This delivery order is placed against a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 3/28/24 |